13F COMBINATION REPORT
Nan Fung Group Holdings Ltd
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001012975-26-000144
Total Value
$111.7M
Positions
27
Other Managers
2
Confidential Omitted
No
Holdings (27)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | EVOMMUNE INC | EVMN | 1,441,032 | $24.7M | 22.08% |
| 2 | MAPLIGHT THERAPEUTICS INC | MPLT | 971,253 | $17.1M | 15.27% |
| 3 | OCULIS HOLDING AG | OCSAW | 514,702 | $10.3M | 9.20% |
| 4 | MADRIGAL PHARMACEUTICALS INC | MDGL | 11,872 | $6.9M | 6.19% |
| 5 | LB PHARMACEUTICALS INC | LBRX | 300,000 | $6.7M | 5.98% |
| 6 | INCYTE CORP | INCY | 59,022 | $5.8M | 5.22% |
| 7 | RHYTHM PHARMACEUTICALS INC | RYTM | 49,120 | $5.3M | 4.71% |
| 8 | BEONE MEDICINES LTD | BEIGF | 15,722 | $4.8M | 4.28% |
| 9 | PROCORE TECHNOLOGIES INC | PCOR | 53,299 | $3.9M | 3.47% |
| 10 | CYBIN INC | HELP | 460,000 | $3.8M | 3.37% |
| 11 | ASCENDIS PHARMA A/S | ASND | 13,600 | $2.9M | 2.60% |
| 12 | ACADIA PHARMACEUTICALS INC | ACAD | 102,984 | $2.8M | 2.46% |
| 13 | RECURSION PHARMACEUTICALS IN | RXRX | 595,287 | $2.4M | 2.18% |
| 14 | STANDARD BIOTOOLS INC | LAB | 1,883,179 | $2.4M | 2.16% |
| 15 | KYMERA THERAPEUTICS INC | KYMR | 30,875 | $2.4M | 2.15% |
| 16 | ARGENX SE | ARGX | 2,800 | $2.4M | 2.11% |
| 17 | REVOLUTION MEDICINES INC | RVMDW | 19,253 | $1.5M | 1.37% |
| 18 | ISHARES ETHEREUM TR | 46438R105 | 50,549 | $1.1M | 1.01% |
| 19 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 27,049 | $1.0M | 0.91% |
| 20 | ISHARES BITCOIN TRUST ETF | IBIT | 15,968 | $792,811 | 0.71% |
| 21 | RANI THERAPEUTICS HLDGS INC | RANI | 493,584 | $666,338 | 0.60% |
| 22 | REPLIMUNE GROUP INC | REPL | 63,719 | $619,349 | 0.55% |
| 23 | ENTRADA THERAPEUTICS INC | TRDA | 49,082 | $504,563 | 0.45% |
| 24 | BICYCLE THERAPEUTICS PLC | BCYC | 68,943 | $488,116 | 0.44% |
| 25 | BOLT BIOTHERAPEUTICS INC | BOLT | 58,347 | $319,041 | 0.29% |
| 26 | ROCKET LAB CORP | RKLB | 3,824 | $266,762 | 0.24% |
| 27 | BOLT PROJS HLDGS INC | 09769B206 | 40,597 | $32,437 | 0.03% |